COBRA™: a highly potent conditionally active T cell engager engineered for the treatment of solid tumors.
Panchal A, Seto P, Wall R, Hillier BJ, Zhu Y, Krakow J, Datt A, Pongo E, Bagheri A, Chen TT, Degenhardt JD, Culp PA, Dettling DE, Vinogradova MV, May C, DuBridge RB.
Panchal A, et al. Among authors: vinogradova mv.
MAbs. 2020 Jan-Dec;12(1):1792130. doi: 10.1080/19420862.2020.1792130.
MAbs. 2020.
PMID: 32684124
Free PMC article.